Profiel
Gilad Rosenberg worked as a Medical Director at Clal Biotechnology Industries Ltd.
and Organon Pharma (UK) Ltd.
He then worked as Vice President-Clinical Development at Univo Pharmaceuticals Ltd.
from 2000 to 2016.
Rosenberg received an undergraduate degree from Technion-Israel Institute of Technology in 1992 and a graduate degree from the University of Oxford in 2005.
Eerdere bekende functies van Gilad Rosenberg
| Bedrijven | Functie | Einde |
|---|---|---|
| UNIVO PHARMACEUTICALS LTD | Corporate Officer/Principal | 07-05-2016 |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Chief Tech/Sci/R&D Officer | - |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Gilad Rosenberg
| University of Oxford | Graduate Degree |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| UNIVO PHARMACEUTICALS LTD | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
